L

Lipella Pharmaceuticals
D

LIPO

2.56000
USD
-0.07
(-2.66%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-4
Market Cap
20,747,868
News

Title: Lipella Pharmaceuticals Inc

Sector: Healthcare
Industry: Biotechnology
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.